B cell tolerance and positive selection in lupus

Journal of Immunology

Volumn 189, Issue 2, 2012, Pages 503-509

  Eilat, Dan ^a   Wabl, Matthias ^b  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; AUTOANTIGEN; DOUBLE STRANDED DNA; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; SINGLE STRANDED DNA; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; TRANSFER RNA; VIRUS DNA;

ADAPTIVE IMMUNITY; AGE; ANTIBODY TITER; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; BINDING AFFINITY; DNA BINDING; GENE; GENE PRODUCT; GENETICS; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; INNATE IMMUNITY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBPOPULATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RETROPOSON; RETROVIRUS; SHORT SURVEY; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; TRANSGENE; V1 GENE; VKAPPA GENE;

ANIMALS; B-LYMPHOCYTE SUBSETS; CELL DIFFERENTIATION; CELL MOVEMENT; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNE TOLERANCE; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED MRL LPR; MICE, INBRED NZB;

EID: 84863622596     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1200848     Document Type: Short Survey

References (79)

1. Burnet, F. M. 1959. The Clonal Slection Theory. Vanderbilt University Press, Nashville, TN.
2. Goodnow, C. C., J. Sprent, B. Fazekas de St Groth, and C. G. Vinuesa. 2005. Cellular and genetic mechanisms of self tolerance and autoimmunity. Nature 435: 590-597. (Pubitemid 40825498)
3. Theofilopoulos, A. N., and F. J. Dixon. 1985. Murine models of systemic lupus erythematosus. Adv. Immunol. 37: 269-390. (Pubitemid 15093080)
4. Wakeland, E. K., K. Liu, R. R. Graham, and T. W. Behrens. 2001. Delineating the genetic basis of systemic lupus erythematosus. Immunity 15: 397-408. (Pubitemid 32907387)
5. Eilat, D., M. Hochberg, J. Pumphrey, and S. Rudikoff. 1984. Monoclonal antibodies to DNA and RNA from NZB/NZW F1 mice: antigenic specificities and NH2 terminal amino acid sequences. J. Immunol. 133: 489-494. (Pubitemid 14082079)
6. Eilat, D., D.M.Webster, and A. R. Rees. 1988. V region sequences of anti-DNA and anti-RNA autoantibodies from NZB/NZW F1 mice. J. Immunol. 141: 1745-1753.
7. Pewzner-Jung, Y., D. Friedmann, E. Sonoda, S. Jung, K. Rajewsky, and D. Eilat. 1998. B cell deletion, anergy, and receptor editing in "knock in" mice targeted with a germline-encoded or somatically mutated anti-DNA heavy chain. J. Immunol. 161: 4634-4645. (Pubitemid 28492037)
8. Friedmann, D., N. Yachimovich, G. Mostoslavsky, Y. Pewzner-Jung, A. Ben-Yehuda, K. Rajewsky, and D. Eilat. 1999. Production of high affinity autoantibodies in autoimmune New Zealand Black/New Zealand white F1 mice targeted with an anti-DNA heavy chain. J. Immunol. 162: 4406-4416. (Pubitemid 29314836)
9. Tillman, D. M., N. T. Jou, R. J. Hill, and T. N. Marion. 1992. Both IgM and IgG anti-DNA antibodies are the products of clonally selective B cell stimulation in (NZB x NZW)F1 mice. J. Exp. Med. 176: 761-779.
10. Behar, S. M., D. L. Lustgarten, S. Corbet, and M. D. Scharff. 1991. Characterization of somatically mutated S107 VH11-encoded anti-DNA autoantibodies derived from autoimmune (NZB × NZW)F1 mice. J. Exp. Med. 173: 731-741.
11. Pewzner-Jung, Y., T. Simon, and D. Eilat. 1996. Structural elements controlling anti-DNA antibody affinity and their relationship to anti-phosphorylcholine activity. J. Immunol. 156: 3065-3073. (Pubitemid 126660658)
12. Shlomchik, M., M. Mascelli, H. Shan, M. Z. Radic, D. Pisetsky, A. Marshak-Rothstein, and M. Weigert. 1990. Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation. J. Exp. Med. 171: 265-292.
13. Radic, M. Z., and M. Weigert. 1994. Genetic and structural evidence for antigen selection of anti-DNA antibodies. Annu. Rev. Immunol. 12: 487-520. (Pubitemid 24140423)
14. Eilat, D., and W. F. Anderson. 1994. Structure-function correlates of autoanti-bodies to nucleic acids: lessons from immunochemical, genetic and structural studies. Mol. Immunol. 31: 1377-1390. (Pubitemid 24381795)
15. Guo,W., D. Smith, K. Aviszus, T. Detanico, R. A. Heiser, and L. J.Wysocki. 2010. Somatic hypermutation as a generator of antinuclear antibodies in a murine model of systemic autoimmunity. J. Exp. Med. 207: 2225-2237.
16. Wellmann, U., M. Letz, M. Herrmann, S. Angermüller, J. R. Kalden, and T. H. Winkler. 2005. The evolution of human anti-double-stranded DNA autoantibodies. Proc. Natl. Acad. Sci. USA 102: 9258-9263. (Pubitemid 40923551)
17. Diamond, B., and M. D. Scharff. 1984. Somatic mutation of the T15 heavy chain gives rise to an antibody with autoantibody specificity. Proc. Natl. Acad. Sci. USA 81: 5841-5844. (Pubitemid 14018499)
18. Papoian, R., R. Pillarisetty, and N. Talal. 1977. Immunological regulation of spontaneous antibodies to DNA and RNA. II. Sequential switch from IgM to IgG in NZB/NZW F1 mice. Immunology 32: 75-79. (Pubitemid 8012123)
19. Nossal, G. J. 1996. Clonal anergy of B cells: a flexible, reversible, and quantitative concept. J. Exp. Med. 183: 1953-1956. (Pubitemid 26158886)
20. Nemazee, D., and M. Weigert. 2000. Revising B cell receptors. J. Exp. Med. 191: 1813-1817. (Pubitemid 30390345)
21. Yachimovich, N., G. Mostoslavsky, Y. Yarkoni, I. Verbovetski, and D. Eilat. 2002. The efficiency of B cell receptor (BCR) editing is dependent on BCR light chain rearrangement status. Eur. J. Immunol. 32: 1164-1174. (Pubitemid 34428834)
22. Yachimovich-Cohen, N., R. Fischel, N. Bachar, Y. Yarkoni, and D. Eilat. 2003. Autoimmune NZB/NZW F1 mice utilize B cell receptor editing for generating high-affinity anti-dsDNA autoantibodies from low-affinity precursors. Eur. J. Immunol. 33: 2469-2478. (Pubitemid 37138979)
23. Lamoureux, J. L., L. C. Watson, M. Cherrier, P. Skog, D. Nemazee, and A. J. Feeney. 2007. Reduced receptor editing in lupus-prone MRL/lpr mice. J. Exp. Med. 204: 2853-2864. (Pubitemid 350179555)
24. Kench, J. A., D. M. Russell, and D. Nemazee. 1998. Efficient peripheral clonal elimination of B lymphocytes in MRL/lpr mice bearing autoantibody transgenes. J. Exp. Med. 188: 909-917. (Pubitemid 28433417)
25. Chen, C., H. Li, Q. Tian, M. Beardall, Y. Xu, N. Casanova, and M. Weigert. 2006. Selection of anti-double-stranded DNA B cells in autoimmune MRL-lpr/lpr mice. J. Immunol. 176: 5183-5190.
26. Kat, I., E. Makdasi, R. Fischel, and D. Eilat. 2010. B-cell anergy is maintained in anti-DNA transgenic NZB/NZW mice. Int. Immunol. 22: 101-111.
27. Huang, W., I. Moisini, R. Bethunaickan, R. Sahu, M. Akerman, D. Eilat, M. Lesser, and A. Davidson. 2011. BAFF/APRIL inhibition decreases selection of naive but not antigen-induced autoreactive B cells in murine systemic lupus erythematosus. J. Immunol. 187: 6571-6580.
28. Klinman, D. M., and A. D. Steinberg. 1987. Systemic autoimmune disease arises from polyclonal B cell activation. J. Exp. Med. 165: 1755-1760. (Pubitemid 17087925)
29. Mannoor, K., A. Matejuk, Y. Xu, M. Beardall, and C. Chen. 2012. Expression of natural autoantibodies in MRL-lpr mice protects from lupus nephritis and improves survival. J. Immunol. 188: 3628-3638.
30. Vettermann, C., K. Herrmann, C. Albert, E. Roth, M. R. Bösl, and H. M. Jäck. 2008. A unique role for the lambda5 nonimmunoglobulin tail in early B lymphocyte development. J. Immunol. 181: 3232-3242.
31. Aït-Azzouzene, D., D. H. Kono, R. Gonzalez-Quintial, L. J. McHeyzer-Williams, M. Lim, D. Wickramarachchi, T. Gerdes, A. L. Gavin, P. Skog, M. G. McHeyzer-Williams, et al. 2010. Deletion of IgG-switched autoreactive B cells and defects in Fas(lpr) lupus mice. J. Immunol. 185: 1015-1027.
32. Cappione, A., III, J. H. Anolik, A. Pugh-Bernard, J. Barnard, P. Dutcher, G. Silverman, and I. Sanz. 2005. Germinal center exclusion of autoreactive B cells is defective in human systemic lupus erythematosus. J. Clin. Invest. 115: 3205-3216. (Pubitemid 41567585)
33. Yurasov, S., H. Wardemann, J. Hammersen, M. Tsuiji, E. Meffre, V. Pascual, and M. C. Nussenzweig. 2005. Defective B cell tolerance checkpoints in systemic lupus erythematosus. J. Exp. Med. 201: 703-711. (Pubitemid 40395116)
34. Mietzner, B., M. Tsuiji, J. Scheid, K. Velinzon, T. Tiller, K. Abraham, J. B. Gonzalez, V. Pascual, D. Stichweh, H. Wardemann, and M. C. Nussenzweig. 2008. Autoreactive IgG memory antibodies in patients with systemic lupus erythematosus arise from nonreactive and polyreactive precursors. Proc. Natl. Acad. Sci. USA 105: 9727-9732. (Pubitemid 352031368)
35. Shlomchik, M. J. 2008. Sites and stages of autoreactive B cell activation and regulation. Immunity 28: 18-28.
36. Seo, S. J., M. L. Fields, J. L. Buckler, A. J. Reed, L. Mandik-Nayak, S. A. Nish, R. J. Noelle, L. A. Turka, F. D. Finkelman, A. J. Caton, and J. Erikson. 2002. The impact of T helper and T regulatory cells on the regulation of anti-double-stranded DNA B cells. Immunity 16: 535-546. (Pubitemid 34442578)
37. Goodnow, C. C., C. G. Vinuesa, K. L. Randall, F. Mackay, and R. Brink. 2010. Control systems and decision making for antibody production. Nat. Immunol. 11: 681-688.
38. Cyster, J. G., S. B. Hartley, and C. C. Goodnow. 1994. Competition for follicular niches excludes self-reactive cells from the recirculating B-cell repertoire. Nature 371: 389-395. (Pubitemid 24302553)
39. Datta, S. K., H. Patel, and D. Berry. 1987. Induction of a cationic shift in IgG anti-DNA autoantibodies: role of T helper cells with classical and novel phenotypes in three murine models of lupus nephritis. J. Exp. Med. 165: 1252-1268. (Pubitemid 17073526)
40. Mohan, C., Y. Yu, L. Morel, P. Yang, and E. K. Wakeland. 1999. Genetic dissection of Sle pathogenesis: Sle3 on murine chromosome 7 impacts T cell activation, differentiation, and cell death. J. Immunol. 162: 6492-6502. (Pubitemid 29309371)
41. Wofsy, D., and W. E. Seaman. 1987. Reversal of advanced murine lupus in NZB/NZW F1 mice by treatment with monoclonal antibody to L3T4. J. Immunol. 138: 3247-3253. (Pubitemid 17071900)
42. Crispín, J. C., S. N. Liossis, K. Kis-Toth, L. A. Lieberman, V. C. Kyttaris, Y. T. Juang, and G. C. Tsokos. 2010. Pathogenesis of human systemic lupus erythematosus: recent advances. Trends Mol. Med. 16: 47-57.
43. Doreau, A., A. Belot, J. Bastid, B. Riche, M. C. Trescol-Biemont, B. Ranchin, N. Fabien, P. Cochat, C. Pouteil-Noble, P. Trolliet, et al. 2009. Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus. Nat. Immunol. 10: 778-785.
44. Hanayama, R., M. Tanaka, K. Miyasaka, K. Aozasa, M. Koike, Y. Uchiyama, and S. Nagata. 2004. Autoimmune disease and impaired uptake of apoptotic cells in MFG-E8-deficient mice. Science 304: 1147-1150. (Pubitemid 38661849)
45. Gaipl, U. S., A. Kuhn, A. Sheriff, L. E. Munoz, S. Franz, R. E. Voll, J. R. Kalden, and M. Herrmann. 2006. Clearance of apoptotic cells in human SLE. Curr. Dir. Autoimmun. 9: 173-187.
46. Nagata, S., R. Hanayama, and K. Kawane. 2010. Autoimmunity and the clearance of dead cells. Cell 140: 619-630.
47. Kawasaki, T., T. Kawai, and S. Akira. 2011. Recognition of nucleic acids by pattern-recognition receptors and its relevance in autoimmunity. Immunol. Rev. 243: 61-73.
48. Rassa, J. C., J. L. Meyers, Y. Zhang, R. Kudaravalli, and S. R. Ross. 2002. Murine retroviruses activate B cells via interaction with Toll-like receptor 4. Proc. Natl. Acad. Sci. USA 99: 2281-2286. (Pubitemid 34169052)
49. Rawlings, D. J., M. A. Schwartz, S. W. Jackson, and A. Meyer-Bahlburg. 2012. Integration of B cell responses through Toll-like receptors and antigen receptors. Nat. Rev. Immunol. 12: 282-294.
50. Christensen, S. R., J. Shupe, K. Nickerson, M. Kashgarian, R. A. Flavell, and M. J. Shlomchik. 2006. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity 25: 417-428. (Pubitemid 44354217)
51. Marshak-Rothstein, A., and I. R. Rifkin. 2007. Immunologically active autoantigens: the role of Toll-like receptors in the development of chronic inflammatory disease. Annu. Rev. Immunol. 25: 419-441. (Pubitemid 46697913)
52. Browne, E. P. 2011. Toll-like receptor 7 controls the anti-retroviral germinal center response. PLoS Pathog. 7: e1002293.
53. Kane, M., L. K. Case, C. Wang, L. Yurkovetskiy, S. Dikiy, and T. V. Golovkina. 2011. Innate immune sensing of retroviral infection via Toll-like receptor 7 occurs upon viral entry. Immunity 35: 135-145.
54. Frankel, W. N., B. K. Lee, J. P. Stoye, J. M. Coffin, and E. M. Eicher. 1992. Characterization of the endogenous nonecotropic murine leukemia viruses of NZB/B1NJ and SM/J inbred strains. Mamm. Genome 2: 110-122.
55. Levy, J. A. 1974. Autoimmunity and neoplasia: the possible role of C-type viruses. Am. J. Clin. Pathol. 62: 258-280.
56. Datta, S. K., N. Manny, C. Andrzejewski, J. André-Schwartz, and R. S. Schwartz. 1978. Genetic studies of autoimmunity and retrovirus expression in crosses of New Zealand black mice. I. Xenotropic virus. J. Exp. Med. 147: 854-871. (Pubitemid 8303497)
57. Izui, S., P. J. McConahey, J. P. Clark, L. M. Hang, I. Hara, and F. J. Dixon. 1981. Retroviral gp70 immune complexes in NZB × NZW F2 mice with murine lupus nephritis. J. Exp. Med. 154: 517-528. (Pubitemid 11044181)
58. Tucker, R. M., C. L. Roark, M. L. Santiago-Raber, S. Izui, and B. L. Kotzin. 2004. Association between nuclear antigens and endogenous retrovirus in the generation of autoantibody responses in murine lupus. Arthritis Rheum. 50: 3626-3636. (Pubitemid 39488690)
59. Stetson, D. B., J. S. Ko, T. Heidmann, and R. Medzhitov. 2008. Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell 134: 587-598.
60. Stetson, D. B., and R. Medzhitov. 2006. Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. Immunity 24: 93-103. (Pubitemid 43077203)
61. Gall, A., P. Treuting, K. B. Elkon, Y. M. Loo, M. Gale, Jr., G. N. Barber, and D. B. Stetson. 2012. Autoimmunity initiates in nonhematopoietic cells and progresses via lymphocytes in an interferon-dependent autoimmune disease. Immunity 36: 120-131.
62. Morita, M., G. Stamp, P. Robins, A. Dulic, I. Rosewell, G. Hrivnak, G. Daly, T. Lindahl, and D. E. Barnes. 2004. Gene-targeted mice lacking the Trex1 (DNase III) 3′->5′ DNA exonuclease develop inflammatory myocarditis. Mol. Cell. Biol. 24: 6719-6727. (Pubitemid 38944351)
63. Crow, Y. J., B. E. Hayward, R. Parmar, P. Robins, A. Leitch, M. Ali, D. N. Black, H. van Bokhoven, H. G. Brunner, B. C. Hamel, et al. 2006. Mutations in the gene encoding the 39-59 DNA exonuclease TREX1 cause Aicardi- Goutières syndrome at the AGS1 locus. Nat. Genet. 38: 917-920. (Pubitemid 44141660)
64. Lee-Kirsch, M. A., D. Chowdhury, S. Harvey, M. Gong, L. Senenko, K. Engel, C. Pfeiffer, T. Hollis, M. Gahr, F. W. Perrino, et al. 2007. A mutation in TREX1 that impairs susceptibility to granzyme A-mediated cell death underlies familial chilblain lupus. J. Mol. Med. 85: 531-537. (Pubitemid 46701663)
65. Lee-Kirsch, M. A., M. Gong, D. Chowdhury, L. Senenko, K. Engel, Y. A. Lee, U. de Silva, S. L. Bailey, T. Witte, T. J. Vyse, et al. 2007. Mutations in the gene encoding the 39-59 DNA exonuclease TREX1 are associated with systemic lupus erythematosus. Nat. Genet. 39: 1065-1067. (Pubitemid 47340647)
66. Beck-Engeser, G. B., D. Eilat, and M. Wabl. 2011. An autoimmune disease prevented by anti-retroviral drugs. Retrovirology 8: 91.
67. Stetson, D. B. 2009. Connections between antiviral defense and autoimmunity. Curr. Opin. Immunol. 21: 244-250.
68. Beck-Engeser, G. B., D. Eilat, T. Harrer, H. M. Jäck, and M. Wabl. 2009. Early onset of autoimmune disease by the retroviral integrase inhibitor raltegravir. Proc. Natl. Acad. Sci. USA 106: 20865-20870.
69. Wang, C. L., and M. Wabl. 2005. Hypermutation rate normalized by chronological time. J. Immunol. 174: 5650-5654. (Pubitemid 40593206)
70. Sullivan, K. E. 2000. Genetics of systemic lupus erythematosus: clinical implications. Rheum. Dis. Clin. North Am. 26: 229-256, v-vi. (Pubitemid 30198758)
71. Putterman, C., and B. Diamond. 1998. Immunization with a peptide surrogate for double-stranded DNA (dsDNA) induces autoantibody production and renal immunoglobulin deposition. J. Exp. Med. 188: 29-38. (Pubitemid 28328603)
72. Subramanian, R. P., J. H. Wildschutte, C. Russo, and J. M. Coffin. 2011. Identification, characterization, and comparative genomic distribution of the HERV-K (HML-2) group of human endogenous retroviruses. Retrovirology 8: 90.
73. Brouha, B., J. Schustak, R. M. Badge, S. Lutz-Prigge, A. H. Farley, J. V. Moran, and H. H. Kazazian, Jr. 2003. Hot L1s account for the bulk of retrotransposition in the human population. Proc. Natl. Acad. Sci. USA 100: 5280-5285. (Pubitemid 36542696)
74. Garaud, S., P. Youinou, and Y. Renaudineau. 2011. DNA methylation and B-cell autoreactivity. Adv. Exp. Med. Biol. 711: 50-60.
75. Bernatsky, S., J. F. Boivin, L. Joseph, R. Rajan, A. Zoma, S. Manzi, E. Ginzler, M. Urowitz, D. Gladman, P. R. Fortin, et al. 2005. An international cohort study of cancer in systemic lupus erythematosus. Arthritis Rheum. 52: 1481-1490. (Pubitemid 40663940)
76. Levy, J. A. 1973. Xenotropic viruses: murine leukemia viruses associated with NIH Swiss, NZB, and other mouse strains. Science 182: 1151-1153.
77. Stephension, J. R., R. K. Reynolds, S. R. Tronick, and S. A. Aaronson. 1975. Distribution of three classes of endogenous type-C RNA viruses among inbred strains of mice. Virology 67: 404-414.
78. Chattopadhyay, S. K., M. R. Lander, E. Rands, and D. R. Lowy. 1980. Structure of endogenous murine leukemia virus DNA in mouse genomes. Proc. Natl. Acad. Sci. USA 77: 5774-5778. (Pubitemid 11206401)
79. Lartigue, A., N. Colliou, S. Calbo, A. François, S. Jacquot, C. Arnoult, F. Tron, D. Gilbert, and P. Musette. 2009. Critical role of TLR2 and TLR4 in autoantibody production and glomerulonephritis in lpr mutation-induced mouse lupus. J. Immunol. 183: 6207-6216.